Patents by Inventor Michael Alan Reeve
Michael Alan Reeve has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7332352Abstract: A composition comprising colloidal Fe3O4 particles coated with streptavidin is disclosed. These particles can be used in a method for separating biotinylated compounds from a solution in which the biotinylated compounds bind to the streptavidin-coated particles which are attracted to a surface by a magnet. Also disclosed is a method for making said streptavidin-coated composition, said method comprising the steps of forming colloidal Fe3O4 particles by mixing aqueous FeCl2 with aqueous FeCl3, adding aliquots of the mixture to an alkaline solution and adding streptavidin.Type: GrantFiled: November 8, 2001Date of Patent: February 19, 2008Assignee: GE Healthcare LimitedInventor: Michael Alan Reeve
-
Publication number: 20020146848Abstract: A composition comprising colloidal Fe3O4 particles coated with streptavidin is disclosed. These particles can be used in a method for separating biotinylated compounds from a solution in which the biotinylated compounds bind to the streptavidin-coated particles which are attracted to a surface by a magnet. Also disclosed is a method for making said streptavidin-coated composition, said method comprising the steps of forming colloidal Fe3O4 particles by mixing aqueous FeCl2 with aqueous FeCl3, adding aliquots of the mixture to an alkaline solution and adding streptavidin.Type: ApplicationFiled: November 8, 2001Publication date: October 10, 2002Inventor: Michael Alan Reeve
-
Patent number: 6399364Abstract: A method of analysing a nucleic acid is disclosed which involves the use of a mixture of labelled oligonucleotides in solution and an array of immobilized oligonucleotides. The target nucleic acid is incubated with the mixture of labelled oligonucleotides. Those labelled oligonucleotides which hybridize are recovered and incubated with the array of immobilized oligonucleotides. Sequence information is obtained by observing the location of the label on the array. The method is particularly suitable for determining differences between nucleic acids.Type: GrantFiled: November 9, 2000Date of Patent: June 4, 2002Assignee: Amersham Biosciences UK LimitedInventors: Michael Alan Reeve, Terek Schwarz
-
Patent number: 6376183Abstract: A method for primer walking cycle sequencing of nucleic acid is provided using a presynthesized set of walking primers wherein the primers have a raised annealing temperature and/or improved annealing properties.Type: GrantFiled: February 14, 2000Date of Patent: April 23, 2002Assignee: Amersham Pharmacia Biotech UK LimitedInventors: Michael Alan Reeve, Philip Steven Robinson, Stuart Ball
-
Patent number: 6083701Abstract: A method determining the number of repeats in a tandem repeat sequence of a nucleic acid target comprises providing an array of nucleic acid probes immobilized at spaced locations on a surface of a support. Each probe of the array has a tandem repeat sequence complementary to that in the target and containing a different number of repeats. When the target is hybridized with the array and forms a perfect match with the probe having the same number of repeats in the tandem repeat sequence, it is not removed by exonuclease treatment and can be detected on the array.Type: GrantFiled: July 29, 1998Date of Patent: July 4, 2000Assignee: Amersham Pharmacia Biotech UK LimitedInventor: Michael Alan Reeve
-
Patent number: 6043059Abstract: A method for primer walking cycle sequencing of nucleic acid is provided using a presynthesized set of walking primers wherein the primers have a raised annealing temperature and/or improved annealing properties without increasing sequence complexity.Type: GrantFiled: March 23, 1998Date of Patent: March 28, 2000Assignee: Amersham Pharmacia Biotech UKInventors: Michael Alan Reeve, Philip Steven Robinson, Stuart Ball
-
Patent number: 5976369Abstract: Biological assay systems often involve suspending magnetically attractable particles in a liquid, and later bringing down the particles from suspension and separating the formed pellet from the supernatant liquid. The invention provides magnetic systems for this purpose, shaped to form an annular or part-annular pellet close to the bottom of the vessel. The systems are suitable for automation.Type: GrantFiled: April 2, 1998Date of Patent: November 2, 1999Assignee: Amersham International plcInventors: Roland Paul Howe, Michael Alan Reeve, Daniel Bischof
-
Patent number: 5897783Abstract: Biological assay systems often involve suspending magnetically attractable particles in a liquid, and later bringing down the particles from suspension and separating the formed pellet from the supernatant liquid. The invention provides magnetic systems for this purpose, shaped to form an annular or part-annular pellet close to the bottom of the vessel. The systems are suitable for automation.Type: GrantFiled: October 13, 1995Date of Patent: April 27, 1999Assignee: Amersham International plcInventors: Roland Paul Howe, Michael Alan Reeve, Daniel Bischof
-
Patent number: 5849542Abstract: A method of sequencing a target nucleic acid using primer extension mass spectroscopy to generate an observed mass spectrum, on which base calling cycles are carried out using calibrated inter-peak mass difference values such that: each called base allows mass calculation for the base-called peak in the observed mass spectrum; this calculated mass is then used as a further calibration point for subsequent rounds of base calling. A reaction mixture of all four base-specific chain extension nucleotides and four chain termination nucleotide analogues. A method of performing mass spectroscopy, which method comprises subjecting molecular ions which have been chemically charged in a predetermined manner to time-of-flight or Fourier transform mass spectroscopy.Type: GrantFiled: May 10, 1996Date of Patent: December 15, 1998Assignee: Amersham Pharmacia Biotech UK LimitedInventors: Michael Alan Reeve, Roland Paul Howe, Terek Schwarz
-
Patent number: 5681946Abstract: A method of recovering a biopolymer from solution involves the use of magnetically attractable beads which do not specifically bind the polymer. The beads are suspended in the solution. Then the polymer is precipitated out of solution and becomes non-specifically associated with the beads. When the beads are magnetically drawn down, the polymer is drawn down with them. The polymer can subsequently be resolubilized and separated from the beads.Type: GrantFiled: April 3, 1996Date of Patent: October 28, 1997Assignee: Amersham International plcInventor: Michael Alan Reeve
-
Patent number: 5670346Abstract: Fluorescently labelled dideoxynucleoside triphosphates are widely used as chain-terminators in Sanger dideoxy sequencing operations. But these unincorporated dye-terminators migrate in an electrophoresis gel and obscure the desired sequence ladder. This invention provides a method and a kit for modifying the unincorporated dye-terminators, e.g. by removal of a 5'-triphosphate group by chemical or enzymatic means e.g. by use of a phosphatase enzyme.Type: GrantFiled: March 7, 1995Date of Patent: September 23, 1997Assignee: Amersham International plcInventors: Michael Alan Reeve, Philip Steven Robinson
-
Patent number: 5665554Abstract: A method of recovering a first material, e.g. plasmid DNA, from a solution containing pre-precipitated second material, e.g. genomic DNA and cellular debris, by precipitating the first material in the presence of magnetically attractable beads which become non-specifically associated with the newly formed precipitate, using a magnet to draw down the beads and the newly formed precipitate, and removing the supernatant.Type: GrantFiled: November 14, 1996Date of Patent: September 9, 1997Assignee: Amersham International PLCInventors: Michael Alan Reeve, Philip Steven Robinson